Late Relapse in Neuroblastoma: Case Report and Review of the Literature.

Curr Pediatr Rev

Pediatric Hematology-Oncology, School of Medicine, Koc University, Istanbul, Turkey.

Published: January 2025

Background: Neuroblastoma is the most com mon extra-cranial solid tu mor in children. The survival rate of relapsed/refractory neuroblastoma is dismal. Late recurrence may occur rarely.

Case Presentation: We have, herein, presented a case with stage IV neuroblastoma who relapsed after 11 years and had a subsequent relapse after 15 years from the initial diagnosis, and reviewed cases with late relapsed (after >5 years) neuroblastoma in the literature. The case presented with recurrent disease at the T7 vertebra after 11 years from the initial diagnosis. The patient received surgery, che motherapy, MIBG treatment, and antiGD2 combined with che motherapy, and had a further local recurrence in the paravertebral area of the re moved T7 vertebra after three years. The patient was operated, received anti-GD2 combined with che motherapy, and is still alive with no symptoms for 19 months after the last relapse.

Conclusion: There is not a well-established treatment regimen for the majority of these patients. MIBG treatment and antiGD2 combined with che motherapy may be promising options for relapsed/ refractory neuroblastoma.

Download full-text PDF

Source
http://dx.doi.org/10.2174/0115733963255648231024081333DOI Listing

Publication Analysis

Top Keywords

che motherapy
16
combined che
12
relapsed years
8
years initial
8
initial diagnosis
8
mibg treatment
8
treatment antigd2
8
antigd2 combined
8
neuroblastoma
6
years
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!